ReviewCells2026
The Vaginal Microbiome-Mitochondria Axis: Implications for Genital Tract Infections.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vaginal microbiome influences epithelial and immune homeostasis through microbial metabolites, virulence factors, and other molecular signals, yet intracellular mechanisms translating microbial activity into host responses remain largely unexplored. Here, we propose the vaginal microbiome-mitochondria axis as a functional framework linking microbial activity to host-cell metabolism, redox signaling, immunity, and cell fate. We integrated evidence from vaginal microbiology, mitochondrial biology, mucosal immunology, and immunometabolism, distinguishing direct observations in the female genital tract from mechanistic evidence obtained in other host-microbe systems. Available evidence indicates that microbial products relevant to vaginal homeostasis and dysbiosis can modulate mitochondrial bioenergetics, reactive oxygen species generation and redox signaling, membrane potential, dynamics, and quality control pathways, while mitochondrial responses can influence epithelial integrity and antimicrobial and inflammatory functions. We further propose that the balance between mitochondrial adaptation and dysfunction may contribute to resolution or persistence of vaginal disorders and that incomplete mitochondrial recovery could contribute to an incomplete microbial ecosystem-host reset and recurrence. Although direct vaginal evidence remains limited, this framework identifies mitochondria as a potentially important functional interface between microbial ecology and host response and generates testable hypotheses for investigating whether mitochondrial homeostasis contributes to durable resolution of vaginal dysbiosis and infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.